? EPIDEMIOLOGY AND CLINICAL RESEARCH INFORMATICS SHARED RESOURCE The Epidemiology and Clinical Research Informatics Shared Resource (ECRISR) serves a crucial dual role in support of both epidemiological and clinical trial research management by providing overall research management expertise and informatics-based management solutions to AECC investigators. The ECRISR has extensive experience supporting all aspects of epidemiological research with a special focus on the development of Study Management Informatics Systems (SMIS) which facilitate the diverse management, data and operational aspects of implementing complex study protocols. The SMIS incorporate automated workflow processes across shared facilities, implement QA and best practices to ensure data integrity, automate data integration from various sources, and establish real-time data monitoring in order to provide efficient research operations, improved data access and progress/regulatory reporting. The SMIS integrate with internal and external EHR and laboratory systems, and support management of multi-center clinical research projects. The ECRISR is responsible for the development, implementation and on-going oversight of a comprehensive clinical trial and research management program to standardize and streamline all AECC clinical trial and research process management. The resource has extensively customized the functionality of the Velos CTRMS to provide QA oversight and facilitate compliance/monitoring of all clinical trial activity. The ECRISR has established workflows, policies and procedures that collaboratively engage, guide and/or provide oversight to other shared resources involved in cancer research. The research management process spans the lifecycle of protocol management from IRB submission to completion and the ECRISR continually expands the purview of the program with the design of custom interfaces between the CTRMS, EPIC and multiple IRB institutional systems to provide fully integrated regulatory and operational management of clinical trials. The ECRISR provides competency and capacity to develop scalable and robust informatics infrastructure which leverage big-data analytic resources to enable a wide spectrum of research across the enterprise. The facility maintains a sophisticated applications framework with data governance and security protocols in compliance with national standards and provides interoperability with other systems to create patient-centered, integrative informatics platforms for comparative effectiveness and preventive care research. The resource participates in national informatics initiatives, develops innovative informatics approaches, provides novel solutions in the realm of data extraction and Quality Assurance. The ECRISR strives to foster interdisciplinary collaboration, serves as a data coordinating center, provides data management services, assists in the development of pilot and grant proposals, and works closely with biostatisticians in the production of complex databases and publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-48
Application #
9998876
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
48
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
081266487
City
Bronx
State
NY
Country
United States
Zip Code
10461
Agalliu, Ilir; Chen, Zigui; Wang, Tao et al. (2018) Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev 27:1168-1175
Bhargava, Ragini; Sandhu, Manbir; Muk, Sanychen et al. (2018) C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun 9:2484
Collu, Giovanna M; Jenny, Andreas; Gaengel, Konstantin et al. (2018) Prickle is phosphorylated by Nemo and targeted for degradation to maintain Prickle/Spiny-legs isoform balance during planar cell polarity establishment. PLoS Genet 14:e1007391
Doyle, Christopher R; Moon, Jee-Young; Daily, Johanna P et al. (2018) A Capsular Polysaccharide-Specific Antibody Alters Streptococcus pneumoniae Gene Expression during Nasopharyngeal Colonization of Mice. Infect Immun 86:
Anayannis, Nicole V; Schlecht, Nicolas F; Ben-Dayan, Miriam et al. (2018) Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma. PLoS One 13:e0191581
Stepankova, Martina; Bartonkova, Iveta; Jiskrova, Eva et al. (2018) Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor. Mol Pharmacol 93:631-644
Maggi, Elaine C; Gravina, Silvia; Cheng, Haiying et al. (2018) Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model. Front Genet 9:6
Ingram, Jessica R; Blomberg, Olga S; Rashidian, Mohammad et al. (2018) Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A 115:3912-3917
Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642
Chen, Zigui; Schiffman, Mark; Herrero, Rolando et al. (2018) Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516:86-101

Showing the most recent 10 out of 1508 publications